【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 23
2 Introduction 26
2.1 Catalyst 26
2.2 Related Reports 27
2.3 Upcoming Related Reports 27
3 Disease Overview 28
3.1 Etiology and Pathophysiology 28
3.1.1 Etiology 28
3.1.2 Pathophysiology 28
3.1.3 Melanoma Biomarkers 29
3.2 Clinical Staging 30
3.3 Symptoms 32
3.4 Prognosis 32
3.5 Quality of Life 34
4 Epidemiology 35
4.1 Disease Background 35
4.2 Risk Factors and Comorbidities 35
4.3 Global Trends 38
4.3.1 US 39
4.3.2 5EU 39
4.3.3 Japan and Australia 39
4.4 Forecast Methodology 40
4.4.1 Sources Used 42
4.4.2 Sources Not Used 49
4.4.3 Forecast Assumptions and Methods 49
4.5 Epidemiological Forecast for Melanoma (2013-2023) 52
4.5.1 Diagnosed Incident Cases of Melanoma 52
4.5.2 Age-Specific Diagnosed Incident Cases of Melanoma 54
4.5.3 Sex-Specific Diagnosed Incident Cases of Melanoma Skin Cancer 56
4.5.4 Age-Standardized Diagnosed Incidence Rates 58
4.5.5 Pathological Stage at Diagnosis 60
4.5.6 Five-Year Diagnosed Prevalent Cases of Melanoma Skin Cancer 61
4.5.7 Five-Year Diagnosed Prevalent Cases of Melanoma Skin Cancer by Genetic Aberrations 63
4.6 Discussion 65
4.6.1 Epidemiological Forecast Insight 65
4.6.2 Limitations of the Analysis 66
4.6.3 Strengths of the Analysis 67
5 Disease Management 68
5.1 Diagnosis Overview 68
5.2 Treatment Overview 69
5.2.1 Localized Melanoma: Stage 0 to Stage IIC 71
5.2.2 Regional Melanoma: Stage IIIA to Stage IIIC 72
5.2.3 Unresectable and Metastatic Melanoma: Stage III and Stage IV 75
5.3 US 81
5.3.1 Screening and Diagnosis 82
5.3.2 Clinical Practices 84
5.4 France 86
5.4.1 Screening and Diagnosis 87
5.4.2 Clinical Practices 87
5.5 Germany 88
5.5.1 Screening and Diagnosis 89
5.5.2 Clinical Practices 90
5.6 Italy 93
5.6.1 Screening and Diagnosis 94
5.6.2 Clinical Practices 94
5.7 Spain 96
5.7.1 Screening and Diagnosis 97
5.7.2 Clinical Practices 97
5.8 UK 98
5.8.1 Screening and Diagnosis 99
5.8.2 Clinical Practices 99
5.9 Japan 101
5.9.1 Screening and Diagnosis 101
5.9.2 Clinical Practices 102
5.10 Australia 103
5.10.1 Screening and Diagnosis 104
5.10.2 Clinical Practices 105
6 Competitive Assessment 108
6.1 Overview 108
6.2 Interferon-based Adjuvant Therapies 110
6.2.1 Roferon-A (Interferon Alfa-2a) 110
6.2.2 Intron A (Interferon Alfa-2b) 114
6.2.3 Sylatron (Peginterferon Alfa-2b) 118
6.3 Immune Checkpoint Inhibitors 124
6.3.1 Yervoy (Ipilimumab) 124
6.3.2 Opdivo (Nivolumab) 134
6.3.3 Keytruda (Pembrolizumab) 143
6.4 BRAF Mutation-targeted Therapies 151
6.4.1 Zelboraf (Vemurafenib) 151
6.4.2 Tafinlar (Dabrafenib) 158
6.4.3 Mekinist (Trametinib) 164
6.5 Other Therapeutic Classes 176
7 Unmet Need and Opportunity 178
7.1 Overview 178
7.2 Therapeutic Options for BRAF Wild-Type Patients 180
7.2.1 Unmet Need 180
7.2.2 Gap Analysis 181
7.2.3 Opportunity 182
7.3 Therapies for Non-responders to PD-1 Immunotherapy 183
7.3.1 Unmet Need 183
7.3.2 Gap Analysis 184
7.3.3 Opportunity 186
7.4 Adjuvant Therapies for High-Risk Resectable Melanoma 188
7.4.1 Unmet Need 188
7.4.2 Gap Analysis 189
7.4.3 Opportunity 191
7.5 Effective Treatment for Brain Metastases 193
7.5.1 Unmet Need 193
7.5.2 Gap Analysis 194
7.5.3 Opportunity 196
7.6 Predictive Markers for Therapeutic Response to Immunotherapies 197
7.6.1 Unmet Need 197
7.6.2 Gap Analysis 198
7.6.3 Opportunity 200
8 Pipeline Assessment 201
8.1 Overview 201
8.2 Promising Drugs in Clinical Development 202
8.3 RAF/RAS/MEK Pathway-Targeting Therapies 204
8.3.1 Cobimetinib (GDC-0973) 204
8.3.2 Encorafenib (LGX818) 211
8.3.3 Binimetinib (MEK162) 217
8.4 Immune-Related Therapies 224
8.4.1 Talimogene Laherparepvec 224
8.4.2 Eltrapuldencel-T (NSB20) 232
8.4.3 Seviprotimut-L (POL-103A) 238
8.4.4 PV-10 244
8.5 Promising Drugs in Early-Stage Development 250
8.5.1 PI3K/Akt/mTOR Pathway-Targeting Therapies 250
8.5.2 Cell Cycle Checkpoint Inhibitors 252
8.5.3 Next-Generation BRAF Inhibitors 254
8.5.4 Immunotherapies 256
8.5.5 Antibody-Drug Conjugates 259
8.6 Other Drugs in Development 261
9 Current and Future Players 263
9.1 Overview 263
9.2 Trends in Corporate Strategy 266
9.3 Company Profiles 267
9.3.1 Bristol-Myers Squibb 267
9.3.2 Novartis 270
9.3.3 Roche 273
9.3.4 Merck 276
10 Market Outlook 280
10.1 Global Markets 280
10.1.1 Forecast 280
10.1.2 Drivers and Barriers — Global Issues 284
10.2 United States 286
10.2.1 Forecast 286
10.2.2 Key Events 290
10.2.3 Drivers and Barriers — US 291
10.3 5EU 293
10.3.1 Forecast 293
10.3.2 Key Events 297
10.3.3 Drivers and Barriers — France 298
10.3.4 Drivers and Barriers — Germany 300
10.3.5 Drivers and Barriers — Italy 301
10.3.6 Drivers and Barriers — Spain 303
10.3.7 Drivers and Barriers — UK 304
10.4 Japan 306
10.4.1 Forecast 306
10.4.2 Key Events 309
10.4.3 Drivers and Barriers — Japan 309
10.5 Australia 311
10.5.1 Forecast 311
10.5.2 Key Events 314
10.5.3 Drivers and Barriers — Australia 315
11 Appendix 317
11.1 Bibliography 317
11.2 Abbreviations 344
11.3 Methodology 349
11.4 Forecasting Methodology 349
11.4.1 Diagnosed Melanoma Patients 349
11.4.2 Percent Drug-Treated Patients 350
11.4.3 Drugs Included in Each Therapeutic Class 350
11.4.4 Launch and Patent Expiry Dates 351
11.4.5 General Pricing Assumptions 352
11.4.6 Average Body Weight and Surface Area Across the 8MM 353
11.4.7 Individual Drug Assumptions 354
11.4.8 Generic Erosion 368
11.4.9 Pricing of Pipeline Agents 368
11.5 Primary Research – KOLs Interviewed for this Report 370
11.6 Primary Research – Prescriber Survey 373
11.7 About the Authors 374
11.7.1 Analyst 374
11.7.2 Therapy Area Director 374
11.7.3 Epidemiologist 375
11.7.4 Global Head of Healthcare 375
11.8 About GlobalData 376
11.9 Disclaimer 376
【レポート販売概要】
■ タイトル:黒色腫治療薬の世界市場予測および分析■ 英文:PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2023
■ 発行日:2015年4月5日
■ 調査会社:GlobalData
■ 商品コード:GDHC104PIDR
■ 調査対象地域:グローバル
- インフルエンザ検査の世界市場2015The report presents a detailed analysis of the Influenza diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Influenza definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals &nb …
- 酸化ストレス測定の世界市場2016-2020About Oxidative Stress Oxidative stress is a state of imbalance caused in cells when a free radical or a reactive oxygen species takes an electron from a molecule and causes a chain reaction leading to cell and tissue damage. Oxidative stress is common in all living organisms and is acceptable to a certain level, beyond which it leads to several biological imbalances and disorders due to the damag …
- Gastroenteritis:グローバル臨床試験レビューH2, 2013Gastroenteritis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Gastroenteritis Global Clinical Trials Review, H2, 2013" provides data on the Gastroenteritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastroenteritis. It includes an overview of the trial numbers and their recruitment status as …
- 太陽電池におけるナノピラー:Nanopillars Making Solar Cells More EfficientAn effort by humans to harness the abundant source of solar energy available around us has manifested in the form solar energy being converted to many applications as diverse as heat channelizing, electricity conversion, electro mechanical applications and many more as these. The dream of solar energy for human applications was realized in the early part of this century by the invention of solar c …
- IoTにおけるビックデータの世界市場:主要動向、機会、予測Billions of devices generate data associated with various enterprise and consumer lifestyle events such as shopping activity, utility usage and other smart grid data, advertisement response, status of goods in transport, weather forecasts, traffic conditions, vehicle maintenance, public transport, downloads and usage of applications, and much more. Big Data and Analytics software and applications …
- 食品向け3Dプリンティングの世界市場予測(~2025年)The 3D food printing market is expected to be valued at USD 425.0 Million by 2025, growing at a CAGR of 54.75% between 2018 and 2025. Some of the key factors driving the growth of this market are increasing the market for customized food and benefits of giving food rich in specific nutrients. 3D food printing has a huge opportunity in the commercial vertical including users such as retail stores, …
- データセンターラック配電ユニット(PDU)の世界市場分析:製品別(基本配電ユニット、計量配電ユニット、インテリジェント配電ユニット)、セグメント予測、2014-2025The global data center rack power distribution unit (PDU) market is expected to reach USD 2.04 billion by 2025, according to a new report by Grand View Research, Inc. In a data center environment, a rack PDU aids in supplying power to server racks. The rising need for reliable power solutions is one of the key factor that is anticipated to have a positive impact on the market growth over the comin …
- 世界のカプロラクタム(ナイロン6繊維/ナイロン6樹脂用途)市場About Caprolactam Caprolactam is an intermediate polymer that is used in the production of nylon 6 fibers and nylon 6 resins, which accounts for 98 percent of the total caprolactam produced. Nylon 6 fibers are used in textiles, carpets, and industrial yarns while nylon 6 resins are used as engineering plastics in the Automotive, Films and Coatings, Wire and Cable, and Electrical industries. Caprol …
- 帯電防止剤の世界市場予測(~2021年):エトキシル化脂肪酸アミン、グリセロールモノステアレート、ジエタノールアミンAntistatic agents are added to polymers in order to remove or reduce the static charge that has accumulated over their surface. Antistatic agents are divided into external and internal agents, based on their applicability. Internal antistatic agents are directly incorporated into the material, whereas, external antistatic agents are applied over the surface of materials. The antistatic agents mark …
- 自動車用HVAC(空調)装置の世界市場:マニュアルHVACシステム、自動HVACシステムAbout Automotive HVAC HVAC is the technology used to provide heating, ventilation, and air conditioning to maintain good air quality and deliver thermal comfort through adequate ventilation inside vehicles. The main principles behind the operation of an HVAC unit are conduction and convention. Heat is transferred from a low-temperature region to high-temperature region inside the vehicle because o …
- 産業制御/FA(ファクトリーオートメーション)の世界市場予測The convergence of the physical and the virtual worlds through Cyber-Physical-Systems (CPS), and the consequent fusion of business processes and technical processes have set the pace of the industrial control and factory automation concept. Industrial Control and Factory Automation brings lot of advantages such as improved efficiency and reduced costs compared to conventional manufacturing process …
- Surge Energy Inc.:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Surge Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Surge Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- バイオシミラーおよび後発生物製剤の世界市場:モノクローナル抗体、融合タンパク質、インスリン、エリスロポエチン、G-CSF、インターフェロン、ヒト成長ホルモン、生殖ホルモンBiosimilar Drugs – Discover Revenue Potential Now, Benefiting Your Authority Do you want to fully understand the sales potentials for biosimilars? This new analysis provides you with revenue forecasts to 2025 at overall world market, therapeutic class and national level. For those therapies you will receive financial data, R&D trends, opportunities and commercial prospects. Visiongain’s updated st …
- Unit Corporation:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Unit Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Unit Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
- 産業オートメーションのグローバル市場動向The Merriam-Webster Online Dictionary defines automation as “the technique of making an apparatus, a process, or a system operate automatically.” Virtually all industries are now using some or the other sort of automation processes in order to increase the overall output and also reduce labor costs. Industrial automation, meanwhile, makes use of robotic devices to complete manufacturing tasks. Ind …